News About: Pharm. Industry
Foreign funds eager to acquire Korean pharmaceutical firms
The merger and acquisition of Korea’s small- and mid-sized companies is talk of town nowadays amid steep Korean won’s slide.
A number of potential bidders who want these companies will remain a lucrative business i...
Novartis Korea appoints Kim as head of Novartis Venture Fund
Novartis Korea said it has appointed Kim Yeon-joon as Head of Novartis’s local venture fund. Kim is currently Medical Scientific Liaison Officer of the company.
This appoint was made following the promotion of Kim ...
Hamel Trade Award 2009 granted to Berna Biotech Korea
The Dutch Business Club Korea (DBCK), in co-operation with the Embassy of the Kingdom of the Netherlands and the Netherlands Foreign Investment Agency awarded Berna Biotech Korea, a Korean unit of Crucell Berna headqu...
Efforts for self-purification are needed
The request report about Pfizer payments to Harvard Medical faculty members in the last two years has haunted the Korean pharmaceutical manufacturers, indicating tough law enforcement in the future in order to induce ...
LG Life Sciences to go global
LG Life Sciences aims to expand its presence in the U.S human hormone growth market worth $1.2 billion with the intention of emerging as one of the best-performing 50 pharmaceutical companies in the world in 2015, a c...
Bukwang receives marketing approval in the Philippines
Bukwang Pharm says the Philippines health authorities have recently granted its market approval to clevudine, an oral, once-daily pyrimidine nucleoside analog that was previously evaluated in 14 clinical trials in mor...
Ildong’s Samion gets momentum
Ildong Pharm's Samion (nicergolin), cererovascular medicine, has fared well since the middle period of last year thanks to the company’s intensive marketing campaigns.
Samion has garnered more than 10 billion won i...
European Union approves blood thinner prasugrel
The European Commission granted marketing authorization for the blood thinner prasugrel, which will be sold in Europe under the brand name Efient, according to Eli Lilly and Daiichi Sankyo who developed prasugrel.
...
Prices of popular OTC brands to rise
The retail prices of popular OTC brands, including Ildong’s Aronamin Gold and Dongwha’s Aphtouch, are expected to rise sooner or later due to falling Korean won.
Customers have seen many OTC prices jump by 6-15 per...
Daewoong to hire 120 interns
Daewoong Pharm and its affiliated companies plan to hire a total of 120 interns in return for lowering wages of executives and existing workers as part of efforts to promote job sharing.
To this end, Daewoong execu...
